Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 6, Pages e0128364
Publisher
Public Library of Science (PLoS)
Online
2015-06-06
DOI
10.1371/journal.pone.0128364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC
- (2014) Katherine R. Amato et al. JOURNAL OF CLINICAL INVESTIGATION
- Ponatinib (AP24534) Is a Novel Potent Inhibitor of Oncogenic RET Mutants Associated With Thyroid Cancer
- (2013) Valentina De Falco et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cabozantinib in Progressive Medullary Thyroid Cancer
- (2013) Rossella Elisei et al. JOURNAL OF CLINICAL ONCOLOGY
- Ponatinib is a potent inhibitor of wild-type and drug-resistant gatekeeper mutant RET kinase
- (2013) Luca Mologni et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Functional characterization of a novel FGFR1OP-RET rearrangement in hematopoietic malignancies
- (2013) Daniela Bossi et al. Molecular Oncology
- Identification of RET gene fusion by exon array analyses in “pan-negative” lung cancer from never smokers
- (2012) Fei Li et al. CELL RESEARCH
- RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation
- (2012) P Ballerini et al. LEUKEMIA
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- (2012) Doron Lipson et al. NATURE MEDICINE
- KIF5B-RET fusions in lung adenocarcinoma
- (2012) Takashi Kohno et al. NATURE MEDICINE
- RET, ROS1 and ALK fusions in lung cancer
- (2012) Kengo Takeuchi et al. NATURE MEDICINE
- A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
- (2011) Y. S. Ju et al. GENOME RESEARCH
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
- (2011) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Multikinase inhibitors: a new option for the treatment of thyroid cancer
- (2011) Matti L. Gild et al. Nature Reviews Endocrinology
- Broad spectrum alkynyl inhibitors of T315I Bcr-Abl
- (2010) Xianming Deng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structural Mechanism of the Pan-BCR-ABL Inhibitor Ponatinib (AP24534): Lessons for Overcoming Kinase Inhibitor Resistance
- (2010) Tianjun Zhou et al. Chemical Biology & Drug Design
- The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells
- (2010) D. Vitagliano et al. ENDOCRINE-RELATED CANCER
- Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors
- (2009) Yongmun Choi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting the RET Pathway in Thyroid Cancer
- (2009) S. A. Wells et al. CLINICAL CANCER RESEARCH
- Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
- (2008) Francesca Carlomagno et al. ENDOCRINE-RELATED CANCER
- The SWISS-MODEL Repository and associated resources
- (2008) F. Kiefer et al. NUCLEIC ACIDS RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started